logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

Hemostemix PR

Hemostemix Provides a Clinical Trial Update and Announces the Release and Filing of 2020 Year-end Audited Financial Statements and Management Discussion and Analysis

Apr 30, 2021

VolitionRx

Rethinking the approach to diagnose cancer | VolitionRx Limited

Apr 30, 2021

Life Science, Technology

Hemostemix PR

Hemostemix Reprices and Amends the Terms of Its Unit Offering and Debenture Offering

Apr 26, 2021

Life Science, Technology

Hemostemix PR

Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up and HMTXF Up-list

Apr 23, 2021

Life Science, Technology

HempFusion PR

HempFusion Comments on Recent Trading Activity, All Projects, Incl. Five Channel Strategy, in Motion and Strong Cash-On-Hand

Apr 15, 2021

Life Science, Technology

赛诺菲首个中国全球研究院成立

Sanofi Unveils First Global Research Institute in China to Develop Innovative Drugs

Apr 14, 2021

Life Science

HempFusion PR

HempFusion’s Products Enter Asia Through Alibaba Group’s Tmall Global

Apr 6, 2021

Life Science

HempFusion PR

HempFusion Provides Operational Update

Apr 5, 2021

Life Science

HempFusion PR

HempFusion Wellness Inc. Reports Filing of Fiscal 2020 Results

Apr 5, 2021

Life Science

HempFusion PR

HempFusion Completes Inflammatory Markers Pilot Trial, Releases White Paper

Mar 25, 2021

Life Science

HempFusion PR

HempFusion Wellness Announces Toxicology Results from Validcare’s Clinical Study on CBD Liver Safety

Mar 23, 2021

Life Science

HempFusion入驻中国电商巨头天猫,对投资者意味着什么

What Does HempFusion Entry onto China’s Ecommerce Giant, Tmall, Mean for Investors?

Mar 18, 2021

Life Science

HempFusion PR

HempFusion Wellness Enters China with Probulin Probiotics Through Alibaba Group’s T-Mall Global, Reaching More Than 750 Million Potential New Consumers

Mar 18, 2021

Life Science

HempFusion PR

HempFusion Is the Top Performing Topical CBD Brand at Major Food-Drug Mass Retailer

Mar 9, 2021

Life Science

HempFusion PR

HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency

Mar 3, 2021

Life Science

NAI500特别报道:随着全球稳固CBD立法,该行业是否处于投资者的临界点?

NAI500 Special Coverage: With Global CBD Legislations Solidifying, is the Industry at a Tipping Point for Investors?

Mar 2, 2021

Cannabis, Life Science

HempFusion PR

HempFusion Wellness Announces Broadening of Share Liquidity With DTC Full-Service Eligibility

Feb 26, 2021

Cannabis, Life Science

医疗保健精选——FDA称针对变异的新冠疫苗不需要漫长的试验;新泽西州休闲大麻正式合法化

Healthcare Roundup – FDA says COVID-19 vaccines targeting variants won’t need lengthy trials; Recreational marijuana use officially legalized in New Jersey

Feb 23, 2021

Life Science

  • ‹‹ Previous
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada